placeholder image
M. E. Miller All authors
About
Publications While At HealthPartners
selected publications
Journal Article
  • Insulin dose and cardiovascular mortality in the ACCORD Trial. 
    Diabetes care. 2015
  • Cognitive function and brain structure in persons with type 2 diabetes mellitus after intensive lowering of blood pressure and lipid levels: a randomized clinical trial. 
    JAMA internal medicine. 2014
  • Durable change in glycaemic control following intensive management of type 2 diabetes in the ACCORD clinical trial. 
    Diabetologia. 2014
  • Poor cognitive function and risk of severe hypoglycemia in type 2 diabetes: post hoc epidemiologic analysis of the ACCORD trial. 
    Diabetes care. 2012
  • Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudy. 
    Lancet Neurology. 2011
  • Long-term effects of intensive glucose lowering on cardiovascular outcomes. 
    New England Journal of Medicine. 2011
  • The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study. 
    BMJ (Clinical research ed.). 2010
  • The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study. 
    BMJ (Clinical research ed.). 2010
  • Effects of intensive glucose lowering in type 2 diabetes. 
    New England Journal of Medicine. 2008
  • Effects of intensive glucose lowering in type 2 diabetes N Engl J Med
    2008
  • Severe hypoglycemia monitoring and risk management procedures in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. 
    American Journal of Cardiology. 2007
    • Contact
    full name
  • M. E. Miller
  • ME Miller
    • Quick Info
     
    Collaboration